Ongoing turbulence continues to take its toll on life science startups looking to raise venture investments. Hear from industry-leading venture investors about the best strategies for healthcare and biotech companies to navigate volatile markets, focusing on creative fundraising, lean operational models, strategic partnerships, and how these decisions can underpin sustained growth and value creation. Learn how a strategic investment syndicate can help successfully steer a startup towards pharma partnerships and product commercialization through troubled times.